• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Related Links
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of High Institute of Public Health
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 55 (2025)
Volume Volume 54 (2024)
Volume Volume 53 (2023)
Volume Volume 52 (2022)
Volume Volume 51 (2021)
Volume Volume 50 (2020)
Volume Volume 49 (2019)
Volume Volume 48 (2018)
Volume Volume 47 (2017)
Volume Volume 46 (2016)
Volume Volume 45 (2015)
Volume Volume 44 (2014)
Volume Volume 43 (2013)
Volume Volume 42 (2012)
Volume Volume 41 (2011)
Volume Volume 40 (2010)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 39 (2009)
Volume Volume 38 (2008)
Volume Volume 37 (2007)
Volume Volume 36 (2006)
Volume Volume 35 (2005)
Volume Volume 34 (2004)
Volume Volume 33 (2003)
Volume Volume 32 (2002)
Volume Volume 31 (2001)
Volume Volume 30 (2000)
Volume Volume 29 (1999)
Zaghaloul, M. (2010). Maternal and Neonatal Outcomes of Induction of Labor with Vaginal Misoprostol Versus Intravenous Oxytocin. Journal of High Institute of Public Health, 40(4), 751-767. doi: 10.21608/jhiph.2010.20632
Mervat Zaghaloul. "Maternal and Neonatal Outcomes of Induction of Labor with Vaginal Misoprostol Versus Intravenous Oxytocin". Journal of High Institute of Public Health, 40, 4, 2010, 751-767. doi: 10.21608/jhiph.2010.20632
Zaghaloul, M. (2010). 'Maternal and Neonatal Outcomes of Induction of Labor with Vaginal Misoprostol Versus Intravenous Oxytocin', Journal of High Institute of Public Health, 40(4), pp. 751-767. doi: 10.21608/jhiph.2010.20632
Zaghaloul, M. Maternal and Neonatal Outcomes of Induction of Labor with Vaginal Misoprostol Versus Intravenous Oxytocin. Journal of High Institute of Public Health, 2010; 40(4): 751-767. doi: 10.21608/jhiph.2010.20632

Maternal and Neonatal Outcomes of Induction of Labor with Vaginal Misoprostol Versus Intravenous Oxytocin

Article 10, Volume 40, Issue 4, October 2010, Page 751-767  XML PDF (263.37 K)
Document Type: Original Article
DOI: 10.21608/jhiph.2010.20632
View on SCiNiTO View on SCiNiTO
Author
Mervat Zaghaloul*
Department of Maternity, Obstetrics and Gynecological Nursing, Faculty of nursing, Port-Said University, Port-Said, Egypt
Abstract
Background: There are many different situations in obstetrics where there is the need for labor induction in women with unripe cervices. This indication stems from a situation where the continuation of pregnancy may be life-threatening for the mother and/or fetus. Objective: To compare maternal and neonatal outcomes of induction of labor with vaginal misoprostol versus intravenous oxytocin. Methods:  A follow up study was conducted at the delivery unit of Ismailia University Hospital. The study subjects included two equal groups of women, group I (50) who received vaginal misoprostol and group II (50) who received oxytocin infusion. A structured interviewing schedule and an observation checklist were developed, validated and used to collect data related to maternal and neonatal outcomes. Results: Uterine contractions of longer duration (>70-90 seconds) and strong intensity were found to be significantly higher in the misoprostol group compared to the oxytocin group (p<0.01). Within the first 12 hours, the misoprostol group recorded statistically significant higher rates of normal fetal heart rate and of vaginal delivery compared to the oxytocin group (p=0.003, 0.008 respectively). On the other hand, the incidence of cesarean delivery was higher in the oxytocin group compared to the misoprostol group. Conclusion and Recommendations: Misoprostol 25μg vaginally (every 4 hours, up to 200 μg) is more safe and efficient for cervical ripening than oxytocin infusion. It is recommended for parturient women with Bishop score ≤4.
Keywords
Apgar score; labor induction; Labor Progress; Vaginal Misoprostol; oxytocin
Statistics
Article View: 214
PDF Download: 577
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.